Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 7:39 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 5,446 | $32.12 | $174,926 | 70,137 (Direct) | View |
| 2023-07-12 Sale | 2023-07-14 6:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 117,000 | $12.07 | $1,412,414 | 54,847 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 4,640 | $29.74 | $137,978 | 47,117 (Direct) | View |
| 2023-01-26 Sale | 2023-01-30 4:05 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,254 | $45.08 | $1,679,510 | 438,559 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:25 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 20,236 | $45.02 | $910,947 | 491,725 (Direct) | View |
| 2023-01-18 Sale | 2023-01-20 4:18 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 47,195 | $45.14 | $2,130,382 | 274,332 (Direct) | View |
| 2022-03-31 Sale | 2022-04-04 8:22 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO | 1,787 | $59.11 | $105,630 | 38,278 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-03 4:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,843 | $0 | 71,254 (Direct) | View |
Ownership | 2024-06-06 6:52 pm | N/A 2034-01-12 | Rapport Therapeutics Inc. | RAPP | Burrell Terry-Ann Director | 0 | $0 | 35,027 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 6:12 pm | N/A 2034-06-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 39,290 | $0 | 95,604 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:10 pm | N/A 2034-04-26 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,500 | $0 | 107,637 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 5:42 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,467 | $0 | 56,314 (Direct) | View |
| 2024-03-31 Option Award | 2024-04-02 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 27,500 | $0 | 75,583 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 55,000 | $24.4 | 55,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:19 pm | 2024-06-16 2033-06-16 | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 37,836 | $0 | 650,549 (Direct) | View |
| 2023-01-31 Option Award(A) | 2023-04-19 4:30 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-03-31 7:46 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 40,000 | $0 | 71,277 (Direct) | View |
| 2023-01-26 Exercise | 2023-01-30 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,254 | $13.68 | 438,559 (Direct) | View |
| 2023-01-26 Exercise | 2023-01-30 4:05 pm | N/A 2029-08-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,254 | $0 | 438,559 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 5:25 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 20,236 | $13.68 | 491,725 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 5:25 pm | N/A 2029-08-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 20,236 | $0 | 491,725 (Direct) | View |
| 2023-01-18 Exercise | 2023-01-20 4:18 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 39,886 | $13.68 | 274,332 (Direct) | View |
| 2023-01-18 Exercise | 2023-01-20 4:18 pm | N/A 2029-08-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 39,886 | $0 | 274,332 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,821 | $0 | 159,235 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 9:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,265 | $0 | 157,414 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 5:48 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,631 | $0 | 156,149 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:12 pm | 2023-06-14 2032-06-14 | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 54,435 | $0 | 607,996 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 7:23 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,788 | $0 | 136,373 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 8:22 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO | 15,000 | $0 | 38,278 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 6:00 pm | N/A 2032-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:41 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 763 | $0 | 134,585 (Direct) | View |